| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A behavioral approach to the neurobiology of schizophrenia
|
Gaebel, W.
|
|
1991
|
4 |
3 |
p. 257-258
2 p.
|
article
|
| 2 |
A carbamazepine augmentation trial in chronic nonresponsive schizophrenia
|
Meszaros, K.
|
|
1991
|
4 |
3 |
p. 291-
1 p.
|
article
|
| 3 |
A comparison of two short term models for multiple family group treatment
|
Lukens, E.P.
|
|
1991
|
4 |
3 |
p. 306-
1 p.
|
article
|
| 4 |
Activation tasks in neuroleptic-induced akathisia
|
Fleischhacker, W.W.
|
|
1991
|
4 |
3 |
p. 363-
1 p.
|
article
|
| 5 |
Acute extrapyramidal syndromes: Clinical characteristics implicate different pathophysiologies
|
Casey, D.E.
|
|
1991
|
4 |
3 |
p. 361-
1 p.
|
article
|
| 6 |
Adjunctive neuropsychological remediation in psychiatric rehabilitation: Program description and priliminary data
|
Jaeger, J.
|
|
1991
|
4 |
3 |
p. 304-305
2 p.
|
article
|
| 7 |
Adult neuropsychological and brain morphological findings in a sample of schizophrenic patients studied with home movies made as children
|
Lewine, R.
|
|
1991
|
4 |
3 |
p. 387-
1 p.
|
article
|
| 8 |
Age dependent changes in dopamine transporter binding and its relevance to schizophrenia
|
Hitri, A.
|
|
1991
|
4 |
3 |
p. 346-
1 p.
|
article
|
| 9 |
Aggressive behavior and the use of seclusion/restraint in chronic schizophrenic patients
|
Dickerson, F.
|
|
1991
|
4 |
3 |
p. 302-
1 p.
|
article
|
| 10 |
A magnetic resonance imaging study comparing treatment-refractory and treatment-responsive schizophrenics
|
Miller, D.D.
|
|
1991
|
4 |
3 |
p. 406-
1 p.
|
article
|
| 11 |
Amphetamine: clinical response of chronic schizophrenics to a single oral dose
|
Bigelow, L.B.
|
|
1991
|
4 |
3 |
p. 313-
1 p.
|
article
|
| 12 |
Analysis of cerebrospinal fluid monoamines in schizophrenic patients on and off neuroleptic treatment and compared with healthy controls
|
Kirch, D.G.
|
|
1991
|
4 |
3 |
p. 349-
1 p.
|
article
|
| 13 |
An animal model of the schizophrenic hippocampus: an attempt to influence fetal hippocampal development by means of maternal viral infection
|
Scheibel, A.B.
|
|
1991
|
4 |
3 |
p. 359-360
2 p.
|
article
|
| 14 |
An autoradiographic study of cholecystokinin receptors in the temporal lobe in post-mortem schizophrenic brains
|
Kerwin, R.W.
|
|
1991
|
4 |
3 |
p. 348-349
2 p.
|
article
|
| 15 |
An electrophysiological investigation of the mechanism of action of the 5-HT2 antagonists ritanserin and MDL 28,133A on amphetamine induced slowing of A10 dopamine neurons
|
Sorensen, S.M.
|
|
1991
|
4 |
3 |
p. 337-338
2 p.
|
article
|
| 16 |
Antibodies from patients with schizophrenia recognize a 68 kD neuronal protein
|
Kilidireas, C.
|
|
1991
|
4 |
3 |
p. 371-372
2 p.
|
article
|
| 17 |
A phenomenological test of the validity of the deficit syndrome
|
Kirkpatrick, B.
|
|
1991
|
4 |
3 |
p. 262-
1 p.
|
article
|
| 18 |
A preparation and fixation technique suitable for quantitative immunohistochemistry and autoradiography of human brain tissue
|
Potkin, S.G.
|
|
1991
|
4 |
3 |
p. 359-
1 p.
|
article
|
| 19 |
Assessment and evaluation of extrapyramidal symptoms of remoxipride and haloperidol in acute treatment of schizophrenia
|
Blomqvist, M.
|
|
1991
|
4 |
3 |
p. 314-
1 p.
|
article
|
| 20 |
Association of pineal gland calcification with neuroleptic dose in chronic schizophrenia
|
Sandyk, R.
|
|
1991
|
4 |
3 |
p. 294-
1 p.
|
article
|
| 21 |
Asymmetries in attentional filtering in left and right visual fields in schizophrenic patients
|
Wigal, S.B.
|
|
1991
|
4 |
3 |
p. 396-
1 p.
|
article
|
| 22 |
A trial of enriched social treatments: Design and outcome
|
Monroe-Blum, H.
|
|
1991
|
4 |
3 |
p. 306-307
2 p.
|
article
|
| 23 |
A trial of L-dopa and molindone in schizophrenia
|
Clardy, J.
|
|
1991
|
4 |
3 |
p. 315-316
2 p.
|
article
|
| 24 |
Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia
|
Sandyk, R.
|
|
1991
|
4 |
3 |
p. 411-412
2 p.
|
article
|
| 25 |
A twin study of prenatal injury markers in psychosis: Timing the insult
|
Bracha, U.S.
|
|
1991
|
4 |
3 |
p. 250-
1 p.
|
article
|
| 26 |
Auditory P300 topography and frontal activation in schizophrenia
|
Merrin, E.L.
|
|
1991
|
4 |
3 |
p. 335-
1 p.
|
article
|
| 27 |
Axis II personality features and disorder in subjects in the New York high-risk project
|
Squires-Wheeler, E.
|
|
1991
|
4 |
3 |
p. 284-285
2 p.
|
article
|
| 28 |
Backward masking deficits in schizophrenia: Implicating a mechanism
|
Green, M.F.
|
|
1991
|
4 |
3 |
p. 384-
1 p.
|
article
|
| 29 |
Behavioral and biochemical effects of methylphenidate infusion in schizophrenic and nonschizophrenic patients
|
Sharma, R.P.
|
|
1991
|
4 |
3 |
p. 356-
1 p.
|
article
|
| 30 |
Behavioral and hormonal response to serotonergic challenge in chronic schizophrenia patients
|
Lindenmayer, J.-P.
|
|
1991
|
4 |
3 |
p. 351-
1 p.
|
article
|
| 31 |
Benzodiazepine responsivity in schizophrenia
|
Wolkowitz, O.M.
|
|
1991
|
4 |
3 |
p. 296-
1 p.
|
article
|
| 32 |
Biochemical pharmacology of the atypical neuroleptic remoxipride
|
Kohler, C.
|
|
1991
|
4 |
3 |
p. 319-
1 p.
|
article
|
| 33 |
Biologic indices of heterogeneity in schizophrenia: Relationship to psychopathology and treatment outcome
|
Lieberman, J.
|
|
1991
|
4 |
3 |
p. 289-290
2 p.
|
article
|
| 34 |
Borna disease virus and schizophrenia: Preliminary results
|
Waltrip, R.W.
|
|
1991
|
4 |
3 |
p. 374-
1 p.
|
article
|
| 35 |
BPRS symptom factors and sleep variables in schizophrenia
|
Benson, K.L.
|
|
1991
|
4 |
3 |
p. 329-330
2 p.
|
article
|
| 36 |
Brain morphology in first episode schizophrenia
|
Lieberman, J.
|
|
1991
|
4 |
3 |
p. 387-388
2 p.
|
article
|
| 37 |
Catecholamine metabolism in psychotic/schizophrenic patients
|
Maas, J.A.
|
|
1991
|
4 |
3 |
p. 352-
1 p.
|
article
|
| 38 |
Central D2 dopaminergic receptor status in treatment responsive and treatment resistant schizophrenic patients as measured by 123I-IBZM single photon emission tomography (SPET)
|
Pilowsky, L.S.
|
|
1991
|
4 |
3 |
p. 410-
1 p.
|
article
|
| 39 |
Cerebral atrophy, signal hyperintensities and ventricular volume in schizophrenia on MRI: Relationship to the presence or absence of tardive dyskinesia
|
Waddington, J.L.
|
|
1991
|
4 |
3 |
p. 369-
1 p.
|
article
|
| 40 |
Cerebrospinal fluid concentrations of dopamine and serotonin metabolites in patients with schizophrenia and schizoaffective disorder: The significance of positive and negative symptoms
|
Risby, E.D.
|
|
1991
|
4 |
3 |
p. 355-
1 p.
|
article
|
| 41 |
Changes of the mRNAs for two dopamine D2 receptor isoforms in rat brain by haloperidol or methamphetamine treatment
|
Sora, I.
|
|
1991
|
4 |
3 |
p. 284-
1 p.
|
article
|
| 42 |
Characteristics of some auditory evoked potential (AEP) and field (AEF) responses (100 ms) in schizophrenia
|
Reeve, A.
|
|
1991
|
4 |
3 |
p. 336-
1 p.
|
article
|
| 43 |
Characterization of genetically transmitted schizophrenia in Danish adoptees
|
Ingraham, L.J.
|
|
1991
|
4 |
3 |
p. 279-280
2 p.
|
article
|
| 44 |
Characterization of positive and negative symptoms in the early course of schizophrenia
|
Ventura, J.
|
|
1991
|
4 |
3 |
p. 270-271
2 p.
|
article
|
| 45 |
Chromosomal aberrations and schizophrenia
|
Bassett, A.S.
|
|
1991
|
4 |
3 |
p. 248-249
2 p.
|
article
|
| 46 |
Chronic clozapine, but not typical antipsychotic agents, increase lymphocyte glucocorticoid receptors in schizophrenics
|
Lowy, M.T.
|
|
1991
|
4 |
3 |
p. 351-352
2 p.
|
article
|
| 47 |
Chronicity, negative symptoms and cognitive disorders of psychotic patients: Implications for treatment
|
Kuipers, T.
|
|
1991
|
4 |
3 |
p. 262-263
2 p.
|
article
|
| 48 |
Clinical and immunological correlates of antibrain IgG autoantibodies in schizophrenic patients
|
Ganguli, R.
|
|
1991
|
4 |
3 |
p. 371-
1 p.
|
article
|
| 49 |
Clinical correlates of plasma HVA during neuroleptic withdrawal
|
Saltz, B.L.
|
|
1991
|
4 |
3 |
p. 293-294
2 p.
|
article
|
| 50 |
Clozapine and tardive dyskinesia: Prospective data
|
Kane, J.M.
|
|
1991
|
4 |
3 |
p. 364-365
2 p.
|
article
|
| 51 |
Clozapine treatment in schizophrenic outpatients: Preliminary results from a double-blind efficacy study
|
Breier, A.
|
|
1991
|
4 |
3 |
p. 315-
1 p.
|
article
|
| 52 |
Cognitive deficits underlying verbal memory function in schizophrenic patients and controls
|
Yurgelun-Todd, D.A.
|
|
1991
|
4 |
3 |
p. 396-397
2 p.
|
article
|
| 53 |
Cognitive impairment and symptomatology associated with postdexamethasone cortisol concentrations in unmedicated schizophrenic patients
|
Newcomer, J.W.
|
|
1991
|
4 |
3 |
p. 353-
1 p.
|
article
|
| 54 |
Comparison methods of quantification of spect brain images in psychiatric research
|
Fenn, D.S.
|
|
1991
|
4 |
3 |
p. 403-
1 p.
|
article
|
| 55 |
Complications of pregnancy and delivery in relation to psychosis in adult life: A study using the perinatal mortality survey
|
Crow, T.J.
|
|
1991
|
4 |
3 |
p. 253-
1 p.
|
article
|
| 56 |
Computer assisted volumetric measurements of MR brain images in schizophrenia
|
Shenton, M.E.
|
|
1991
|
4 |
3 |
p. 413-
1 p.
|
article
|
| 57 |
Coping behavior in schizophrenic patients in terms of a situation/operation theory of stress and coping
|
Boker, W.
|
|
1991
|
4 |
3 |
p. 300-
1 p.
|
article
|
| 58 |
Correlates of course and outcome in first-episode schizophrenia
|
Loebel, A.
|
|
1991
|
4 |
3 |
p. 290-
1 p.
|
article
|
| 59 |
Correlates of suicidal ideation in post-psychotic depression
|
Siris, S.G.
|
|
1991
|
4 |
3 |
p. 378-
1 p.
|
article
|
| 60 |
Correlation between changes in neurotransmitter receptor densities and chronic GABA agonist actions on haloperidol-induced vacuous chewing movements
|
Shirakawa, O.
|
|
1991
|
4 |
3 |
p. 366-367
2 p.
|
article
|
| 61 |
Critical issues in the study of prepulse inhibition of acoustic startle: A measure of sensory gating related to mesolimbic dopamine activity
|
Schwarzkopf, S.B.
|
|
1991
|
4 |
3 |
p. 392-
1 p.
|
article
|
| 62 |
CSF neurotransmitter changes during clozapine pharmacotherapy in schizophrenia
|
Risch, S.C.
|
|
1991
|
4 |
3 |
p. 324-325
2 p.
|
article
|
| 63 |
Decreased substance P- and increased calcitonin gene-related peptide immunoreactivities in the cerebrospinal fluid of drug-naive schizophrenic patients
|
Fleischhacker, W.W.
|
|
1991
|
4 |
3 |
p. 344-345
2 p.
|
article
|
| 64 |
Delta sleep inducing peptide-like immunoreactivity and sleep EEG results in schizophrenia
|
Peters, J.L.
|
|
1991
|
4 |
3 |
p. 336-
1 p.
|
article
|
| 65 |
Dementia in elderly schizophrenic patients
|
Davidson, M.
|
|
1991
|
4 |
3 |
p. 275-276
2 p.
|
article
|
| 66 |
Deterioration in premorbid functioning: A developmental model of negative symptoms
|
Kelly, M.E.
|
|
1991
|
4 |
3 |
p. 261-
1 p.
|
article
|
| 67 |
Development of cognitive and electrophysiological measures of selective attention for genetic linkage studies of schizophrenia
|
Emmerson, R.Y.
|
|
1991
|
4 |
3 |
p. 255-
1 p.
|
article
|
| 68 |
Development of drug-induced parkinsonism in elderly individuals receiving neuroleptics for the first time
|
Saltz, B.L.
|
|
1991
|
4 |
3 |
p. 365-366
2 p.
|
article
|
| 69 |
Diagnosis of Blacks in a state system
|
Lawson, W.B.
|
|
1991
|
4 |
3 |
p. 263-
1 p.
|
article
|
| 70 |
Differential effect of clozapine on psychopathology and cognitive dysfunction in treatment-resistant schizophrenics
|
Kenny, J.T.
|
|
1991
|
4 |
3 |
p. 386-387
2 p.
|
article
|
| 71 |
Dimensionality of a neuropsychiatric soft sign battery
|
Faber, R.
|
|
1991
|
4 |
3 |
p. 382-383
2 p.
|
article
|
| 72 |
Discriminating characteristics between schizophrenic and “schizoaffective” patients
|
Beasley, L.
|
|
1991
|
4 |
3 |
p. 299-
1 p.
|
article
|
| 73 |
Disengagement of attention in schizophrenia
|
Strauss, M.E.
|
|
1991
|
4 |
3 |
p. 394-
1 p.
|
article
|
| 74 |
Distribution of dopamine D-2 receptors in the monkey and human neocortex
|
Lidow, M.S.
|
|
1991
|
4 |
3 |
p. 350-351
2 p.
|
article
|
| 75 |
Dopamine (D2) agonist receptor binding properties of [3H]U-86170
|
Lahti, R.A.
|
|
1991
|
4 |
3 |
p. 319-320
2 p.
|
article
|
| 76 |
Dopamine-hydroxylase-like immunoreactivity in schizophrenia: Premorbid functioning and drug response
|
van Kammen, D.P.
|
|
1991
|
4 |
3 |
p. 356-
1 p.
|
article
|
| 77 |
Editorial acknowledgement
|
Nasrallah, Henry A.
|
|
1991
|
4 |
3 |
p. 246-
1 p.
|
article
|
| 78 |
EEG-brain mapping—A useful predictor of the efficiency of neuroleptic therapy in schizophrenic patients
|
Schellenberg, R.
|
|
1991
|
4 |
3 |
p. 337-
1 p.
|
article
|
| 79 |
EEG photic driving in chronic PCP users, schizophrenic patients, and normal controls
|
Jin, Y.
|
|
1991
|
4 |
3 |
p. 333-334
2 p.
|
article
|
| 80 |
Effect of neuroleptic withdrawal on the relationship of tardive dyskinesia and ventricular enlargement
|
Hoffman, W.F.
|
|
1991
|
4 |
3 |
p. 364-
1 p.
|
article
|
| 81 |
Effect of typical and atypical antipsychotic drugs on the in vivo binding of [3H]N-methyl-spiperone to serotonin-2 and dopamine-2 receptors in rat brain
|
Stockmeier, C.A.
|
|
1991
|
4 |
3 |
p. 326-327
2 p.
|
article
|
| 82 |
Effects of clozapine on cognition in patients with schizophrenia
|
Greenberg, R.
|
|
1991
|
4 |
3 |
p. 385-
1 p.
|
article
|
| 83 |
Effects of famotidine, a histamine H2-receptor antagonist, on negative symptoms of schizophrenia
|
Kaminski, R.
|
|
1991
|
4 |
3 |
p. 318-319
2 p.
|
article
|
| 84 |
Effects of leucotomy lesion size and location on personality and intellect
|
Swayze II, V.W.
|
|
1991
|
4 |
3 |
p. 395-
1 p.
|
article
|
| 85 |
Effects of methamphetamine and MK-801 on dopamine in the striatum of awake rats: In vivo brain microdialysis and behavioral measures
|
Marshall, J.F.
|
|
1991
|
4 |
3 |
p. 352-
1 p.
|
article
|
| 86 |
Efficacy and tolerability of clozapine in the treatment of 425 schizophrenic patients
|
Naber, D.
|
|
1991
|
4 |
3 |
p. 322-323
2 p.
|
article
|
| 87 |
Efficacy and tolerability of the partial dopamine agonist SDZ HDC 912 in the treatment of schizophrenia
|
Naber, D.
|
|
1991
|
4 |
3 |
p. 323-
1 p.
|
article
|
| 88 |
Elevated central levels of interleukin-2 in drug-free schizophrenic patients
|
Licinio, J.
|
|
1991
|
4 |
3 |
p. 372-
1 p.
|
article
|
| 89 |
Epidemiology of schizophrenia in rural Ireland: Evidence for geographical variations in prevalence
|
Youssef, H.A.
|
|
1991
|
4 |
3 |
p. 271-
1 p.
|
article
|
| 90 |
Ethnic differences in schizophrenia
|
Mance, R.
|
|
1991
|
4 |
3 |
p. 264-
1 p.
|
article
|
| 91 |
Evaluating neuropsychological impairments in adult schizophrenic inpatients with a childhood age of onset: A preliminary report
|
Hoff, A.L.
|
|
1991
|
4 |
3 |
p. 386-
1 p.
|
article
|
| 92 |
Evidence for an early antipsychotic effect of neuroleptics in patients with chronic schizophrenia
|
Stern, R.G.
|
|
1991
|
4 |
3 |
p. 294-295
2 p.
|
article
|
| 93 |
Evidence for structural and functional pre-frontal impairments in schizophrenia
|
Raine, A.
|
|
1991
|
4 |
3 |
p. 411-
1 p.
|
article
|
| 94 |
Evidence of early brain changes in subgroup of twins with schizophrenia
|
Torrey, E.F.
|
|
1991
|
4 |
3 |
p. 285-
1 p.
|
article
|
| 95 |
Expressed Emotion (EE) and the targeted medication approach
|
Hanlon, T.E.
|
|
1991
|
4 |
3 |
p. 304-
1 p.
|
article
|
| 96 |
Factors associated with medication noncompliance in schizophrenic patients
|
Albus, M.
|
|
1991
|
4 |
3 |
p. 287-
1 p.
|
article
|
| 97 |
Family interaction vs. individual psychopathology
|
Goldstein, M.J.
|
|
1991
|
4 |
3 |
p. 303-304
2 p.
|
article
|
| 98 |
Family involvement in the management of schizophrenia-evaluation of a new model
|
Katsching, H.
|
|
1991
|
4 |
3 |
p. 305-306
2 p.
|
article
|
| 99 |
Forms of memory failure in schizophrenia
|
Gold, J.M.
|
|
1991
|
4 |
3 |
p. 383-384
2 p.
|
article
|
| 100 |
From antibody to gene in schizophrenia: Methodology and progress report
|
Honer, W.G.
|
|
1991
|
4 |
3 |
p. 278-279
2 p.
|
article
|
| 101 |
Frontal and right-left differences in schizophrenic vs normal subjects: A magnetic resonance brain imaging (MRI) study
|
DeMyer, M.K.
|
|
1991
|
4 |
3 |
p. 402-403
2 p.
|
article
|
| 102 |
Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of a geometrical reconnaissance task
|
Gallhofer, B.
|
|
1991
|
4 |
3 |
p. 332-333
2 p.
|
article
|
| 103 |
Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of an arythmetic task
|
Kunz, S.
|
|
1991
|
4 |
3 |
p. 334-
1 p.
|
article
|
| 104 |
Gender differences in cognitive functioning and symptoms in schizophrenics
|
Addington, J.
|
|
1991
|
4 |
3 |
p. 273-
1 p.
|
article
|
| 105 |
Gender differences in schizophrenia
|
Haas, G.L.
|
|
1991
|
4 |
3 |
p. 277-
1 p.
|
article
|
| 106 |
Gender differences in the familial transmission of schizophrenia
|
Goldstein, J.M.
|
|
1991
|
4 |
3 |
p. 258-259
2 p.
|
article
|
| 107 |
Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia
|
Childers, S.E.
|
|
1991
|
4 |
3 |
p. 252-
1 p.
|
article
|
| 108 |
Genetic linkage analysis study of schizophrenia in Canadian families: Clinical assessment results
|
Bassett, A.S.
|
|
1991
|
4 |
3 |
p. 249-
1 p.
|
article
|
| 109 |
Genetic linkage studies in schizophrenia using (CA)n repeat polymorphisms
|
Polymeropoulos, M.H.
|
|
1991
|
4 |
3 |
p. 283-
1 p.
|
article
|
| 110 |
Genetic versus environmental rorschach variables in the Finnish adoptive family study of schizophrenia
|
Wahlberg, K.-E.
|
|
1991
|
4 |
3 |
p. 309-310
2 p.
|
article
|
| 111 |
Haloperidol kinetics and clinical response
|
Conley, R.
|
|
1991
|
4 |
3 |
p. 287-
1 p.
|
article
|
| 112 |
Hard neurologic signs and obstetric complications: Evidence for etiologic roles in schizophrenia
|
Kinney, D.K.
|
|
1991
|
4 |
3 |
p. 261-262
2 p.
|
article
|
| 113 |
Heart rate variability in schizophrenia
|
Dalack, G.W.
|
|
1991
|
4 |
3 |
p. 332-
1 p.
|
article
|
| 114 |
Ibotenic acid or ablation lesions of the frontal cortex do not alter the density or the affinity of D1 and D2 receptors in the corpus striatum or nucleus accumbens
|
Jaskiw, G.E.
|
|
1991
|
4 |
3 |
p. 346-347
2 p.
|
article
|
| 115 |
Identification of subgroups of poorly responsive schizophrenics
|
Raymond, R.
|
|
1991
|
4 |
3 |
p. 324-
1 p.
|
article
|
| 116 |
Immunohistochemistry of neuropeptides in tardive dyskinesia
|
Falkai, P.
|
|
1991
|
4 |
3 |
p. 362-
1 p.
|
article
|
| 117 |
Impaired implicit memory in schizophrenia: A selective deficit?
|
Heinrichs, R.W.
|
|
1991
|
4 |
3 |
p. 385-
1 p.
|
article
|
| 118 |
Impaired social functioning and schizophrenia: A familial association?
|
Brunke, J.J.
|
|
1991
|
4 |
3 |
p. 250-251
2 p.
|
article
|
| 119 |
Implicit memory function in schizophrenia
|
Randolph, C.
|
|
1991
|
4 |
3 |
p. 391-
1 p.
|
article
|
| 120 |
Implicit versus explicit memory in schizophrenia
|
Myles-Worsley, M.
|
|
1991
|
4 |
3 |
p. 389-
1 p.
|
article
|
| 121 |
Increased percentages of T lymphocytes in the CSF of schizophrenic patients
|
McAllister, C.G.
|
|
1991
|
4 |
3 |
p. 373-
1 p.
|
article
|
| 122 |
Index of first authors
|
|
|
1991
|
4 |
3 |
p. 417-420
4 p.
|
article
|
| 123 |
Information processing impairment in Finnish adopted-away offspring of schizophrenic mothers and control mothers
|
Moring, J.
|
|
1991
|
4 |
3 |
p. 282-
1 p.
|
article
|
| 124 |
Initial experience with clozapine in Oregon's State Hospitals
|
Wilson, W.H.
|
|
1991
|
4 |
3 |
p. 327-328
2 p.
|
article
|
| 125 |
Inside the black box called “expressed emotion”: A theoretical critique of the construct in psychiatric research
|
Jenkins, J.H.
|
|
1991
|
4 |
3 |
p. 305-
1 p.
|
article
|
| 126 |
Insight and its related factors of chronic schizophrenic patients
|
Takai, A.
|
|
1991
|
4 |
3 |
p. 309-
1 p.
|
article
|
| 127 |
Investigations of abnormal selective attention as a possible vulnerability marker for schizophrenia
|
Myles-Worsley, M.
|
|
1991
|
4 |
3 |
p. 389-390
2 p.
|
article
|
| 128 |
Is delusional disorder different from schizophrenia?
|
Jeste, D.V.
|
|
1991
|
4 |
3 |
p. 260-
1 p.
|
article
|
| 129 |
Kraepelinian schizophrenia: A replication in an independent sample
|
Frecska, E.
|
|
1991
|
4 |
3 |
p. 257-
1 p.
|
article
|
| 130 |
Latent inhibition-based animal models: Implications of effects of phencyclidine and clozapine
|
Christison, G.W.
|
|
1991
|
4 |
3 |
p. 331-332
2 p.
|
article
|
| 131 |
Lateral and third ventricular volumes in schizophrenics and their siblings: Effect of spectrum diagnosis
|
Olson, S.C.
|
|
1991
|
4 |
3 |
p. 407-408
2 p.
|
article
|
| 132 |
Lateralized differences in reaction time in schizophrenic patients
|
Wigal, S.B.
|
|
1991
|
4 |
3 |
p. 396-
1 p.
|
article
|
| 133 |
Left-handedness in schizophrenia is associated with increased impairment on the Luria-Nebraska neuropsychological battery
|
Faustman, W.O.
|
|
1991
|
4 |
3 |
p. 383-
1 p.
|
article
|
| 134 |
Life events and prodromal symptoms in schizophrenia
|
Herz, M.I.
|
|
1991
|
4 |
3 |
p. 289-
1 p.
|
article
|
| 135 |
Limbic system morphology in schizophrenia: A comparison of new post mortem and MRI data
|
Bogerts, B.
|
|
1991
|
4 |
3 |
p. 400-
1 p.
|
article
|
| 136 |
Linkage analysis of six schizophrenia pedigrees with 150 DNA markers
|
Byerley, W.
|
|
1991
|
4 |
3 |
p. 274-275
2 p.
|
article
|
| 137 |
Linkage map of schizophrenia 11q
|
Gill, M.
|
|
1991
|
4 |
3 |
p. 258-
1 p.
|
article
|
| 138 |
Linkage studies of two new genes of neuropsychiatric interest
|
Kennedy, J.L.
|
|
1991
|
4 |
3 |
p. 280-
1 p.
|
article
|
| 139 |
Lithium carbonate added to neuroleptics in treatment refractory schizophrenia
|
Meszaros, K.
|
|
1991
|
4 |
3 |
p. 291-292
2 p.
|
article
|
| 140 |
Lithium in combination with perphenazine: Effect on plasma monoamine metabolities
|
Bowers, M.B.
|
|
1991
|
4 |
3 |
p. 341-342
2 p.
|
article
|
| 141 |
Low amounts of the α subunit of GTP-binding protein Go in orbital frontal cortex of schizophrenic brain: Biochemical evidence of the hypofrontality hypothesis of schizophrenia
|
Okada, F.
|
|
1991
|
4 |
3 |
p. 353-354
2 p.
|
article
|
| 142 |
Maintenance of grip-induced muscle tension as a marker variable in schizophrenia
|
Rosen, A.J.
|
|
1991
|
4 |
3 |
p. 391-392
2 p.
|
article
|
| 143 |
MCPP effects in schizophrenic patients before and after typical and atypical neuroleptic treatment
|
Krystal, J.H.
|
|
1991
|
4 |
3 |
p. 350-
1 p.
|
article
|
| 144 |
Measures of shifts in covert visual attention and eye movements in schizophrenia
|
Moran, M.
|
|
1991
|
4 |
3 |
p. 388-389
2 p.
|
article
|
| 145 |
Measuring the character of community treatments for schizophrenics: Implications for efficacy and heterogeneity
|
Brekke, J.S.
|
|
1991
|
4 |
3 |
p. 300-301
2 p.
|
article
|
| 146 |
Memory, frontal and other cognitive impairments in schizophrenia—A neuropsychological study
|
McKenna, P.J.
|
|
1991
|
4 |
3 |
p. 388-
1 p.
|
article
|
| 147 |
Memory function in monozygotic twins discordant for schizophrenia
|
Goldberg, T.E.
|
|
1991
|
4 |
3 |
p. 384-
1 p.
|
article
|
| 148 |
Mesial temporal volume changes on MRI in schizophrenic and affective patients
|
Pearlson, G.D.
|
|
1991
|
4 |
3 |
p. 409-
1 p.
|
article
|
| 149 |
Monitoring service implementation in controlled services trials
|
Hargreaves, W.A.
|
|
1991
|
4 |
3 |
p. 289-
1 p.
|
article
|
| 150 |
Morphometric study of prefrontal cortex and limbic structures in schizophrenia
|
Breier, A.
|
|
1991
|
4 |
3 |
p. 400-
1 p.
|
article
|
| 151 |
MRI and PET studies in late life-onset schizophrenics
|
Pearlson, G.D.
|
|
1991
|
4 |
3 |
p. 409-410
2 p.
|
article
|
| 152 |
MRI findings as a predictor of clozapine response
|
Jewart, R.D.
|
|
1991
|
4 |
3 |
p. 406-
1 p.
|
article
|
| 153 |
99m-technetium single photon emission imaging in chronic schizophrenia and healthy volunteers
|
Ford, R.
|
|
1991
|
4 |
3 |
p. 404-
1 p.
|
article
|
| 154 |
Negative schizophrenia as a variant of parkinsonism
|
Sandyk, R.
|
|
1991
|
4 |
3 |
p. 266-267
2 p.
|
article
|
| 155 |
Negative symptoms, neuropsychological findings, and ventricular enlargement in schizophrenia
|
DeQuardo, J.R.
|
|
1991
|
4 |
3 |
p. 254-255
2 p.
|
article
|
| 156 |
Neurodevelopmental indicators of vulnerability for schizophrenia
|
Walker, E.F.
|
|
1991
|
4 |
3 |
p. 285-286
2 p.
|
article
|
| 157 |
Neuroendocrine determinants of disturbed water regulation in schizophrenia
|
Lawson, W.B.
|
|
1991
|
4 |
3 |
p. 377-378
2 p.
|
article
|
| 158 |
Neuroendocrinological and neurochemical effects of the sigma ‘antagonist’ BMY 14802
|
Gudelsky, G.A.
|
|
1991
|
4 |
3 |
p. 318-
1 p.
|
article
|
| 159 |
Neuroleptic-induced changes in gene expression in rat brain
|
Cohen, B.M.
|
|
1991
|
4 |
3 |
p. 342-343
2 p.
|
article
|
| 160 |
Neurological soft signs in schizophrenic patients
|
Mohr, F.
|
|
1991
|
4 |
3 |
p. 264-265
2 p.
|
article
|
| 161 |
Neurologic sequelae of psychogenic polydipsia
|
Conley, R.
|
|
1991
|
4 |
3 |
p. 376-
1 p.
|
article
|
| 162 |
Neuropeptide Y like immunoreactivity in schizophrenia: Relationships with clinical measures
|
Peters, J.
|
|
1991
|
4 |
3 |
p. 355-
1 p.
|
article
|
| 163 |
Neuropsychological deficit and symptomatology: Evidence for the heterogeneity of positive symptoms
|
O'Leary, D.S.
|
|
1991
|
4 |
3 |
p. 266-
1 p.
|
article
|
| 164 |
Neuropsychological deviations in healthy relatives of schizophrenics
|
Maier, W.
|
|
1991
|
4 |
3 |
p. 280-281
2 p.
|
article
|
| 165 |
Neuropsychological impairments are increased in siblings of schizophrenic patients
|
Pogue-Geile, M.F.
|
|
1991
|
4 |
3 |
p. 390-
1 p.
|
article
|
| 166 |
Neuropsychological studies of first episode schizophrenia
|
Bilder, R.M.
|
|
1991
|
4 |
3 |
p. 381-382
2 p.
|
article
|
| 167 |
Obstetric complications in schizophrenia
|
Davis, O.R.
|
|
1991
|
4 |
3 |
p. 254-
1 p.
|
article
|
| 168 |
Oculomotor studies in schizophrenic patients with and without tardive dyskinesia
|
Thaker, G.
|
|
1991
|
4 |
3 |
p. 368-
1 p.
|
article
|
| 169 |
Onset and premorbid clinical features of psychosis in the New York high-risk project
|
Bassett, A.S.
|
|
1991
|
4 |
3 |
p. 273-274
2 p.
|
article
|
| 170 |
On the clinical profile of remoxipride—Experiences from a clinical trial programme in the acute treatment of schizophrenia
|
Lewander, T.
|
|
1991
|
4 |
3 |
p. 321-
1 p.
|
article
|
| 171 |
Pathogenic traits in schizophrenia
|
Spohn, H.E.
|
|
1991
|
4 |
3 |
p. 267-268
2 p.
|
article
|
| 172 |
Patterns of psychophysiological and acoustic responses and flat affect in schizophrenia
|
Sison, C.E.
|
|
1991
|
4 |
3 |
p. 267-
1 p.
|
article
|
| 173 |
Persistent tardive dyskinesia, caudate atrophy on CT scan, and regional cerebral blood flow findings in schizophrenia
|
Mukherjee, S.
|
|
1991
|
4 |
3 |
p. 365-
1 p.
|
article
|
| 174 |
PET studies of frontal lobe function during cognition
|
Berman, K.F.
|
|
1991
|
4 |
3 |
p. 399-
1 p.
|
article
|
| 175 |
P300 event-related potential components and axis II-schizophrenia-related features and disorders
|
Squires-Wheeler, E.
|
|
1991
|
4 |
3 |
p. 338-
1 p.
|
article
|
| 176 |
Pharmacological evaluation of sertindole: A new atypical neuroleptic
|
Skarsfeldt, T.
|
|
1991
|
4 |
3 |
p. 326-
1 p.
|
article
|
| 177 |
Pharmacological properties of SDZ 212-327, a novel antipsychotic candidate
|
Markstein, R.
|
|
1991
|
4 |
3 |
p. 322-
1 p.
|
article
|
| 178 |
Phase I trials of BMY 14802, a potential antipsychotic with affinity for sigma binding sites
|
Taylor, D.P.
|
|
1991
|
4 |
3 |
p. 327-
1 p.
|
article
|
| 179 |
Phase of illness and suicide in schizophrenia
|
Weiden, P.J.
|
|
1991
|
4 |
3 |
p. 379-
1 p.
|
article
|
| 180 |
Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients
|
Van Putten, T.
|
|
1991
|
4 |
3 |
p. 295-
1 p.
|
article
|
| 181 |
Plasma homovanillic acid and drug response in schizophrenia
|
Diamond, B.I.
|
|
1991
|
4 |
3 |
p. 343-344
2 p.
|
article
|
| 182 |
Plasma homovanillic acid concentrations decrease in responders, but not in non-responders, to neuroleptic treatment
|
Kahn, R.S.
|
|
1991
|
4 |
3 |
p. 347-
1 p.
|
article
|
| 183 |
Plasma HVA correlates of attentional performance in unmedicated schizophrenics
|
Harvey, P.D.
|
|
1991
|
4 |
3 |
p. 345-346
2 p.
|
article
|
| 184 |
Plasma level determination of haloperidol and reduced haloperidol in patients with treatment refractory schizophrenia by gas chromatography-mass spectrometry
|
Reed, K.L.
|
|
1991
|
4 |
3 |
p. 293-
1 p.
|
article
|
| 185 |
Plasma level monitoring of depot neuroleptics
|
Marder, S.R.
|
|
1991
|
4 |
3 |
p. 290-291
2 p.
|
article
|
| 186 |
Platelet [3H] dopamine uptake in patients with schizophrenia and non-schizophrenic psychoses: Its relationship to psychopathology
|
Copolov, D.
|
|
1991
|
4 |
3 |
p. 343-
1 p.
|
article
|
| 187 |
Polydipsia-hyponatremia: Evidence for specific cerebral structural pathology and implications for the pathophysiology of schizophrenia
|
Kirch, D.G.
|
|
1991
|
4 |
3 |
p. 377-
1 p.
|
article
|
| 188 |
Positron emission tomography study of phencyclidine users
|
Wu, J.C.
|
|
1991
|
4 |
3 |
p. 415-
1 p.
|
article
|
| 189 |
-3PPP effects on local cerebral glucose utilization in the rat
|
Dixon, L.B.
|
|
1991
|
4 |
3 |
p. 316-317
2 p.
|
article
|
| 190 |
Predicting skill acquisition in social skills training for schizophrenia and schizoaffective disorder: The role of memory and symptomatology
|
Mueser, K.T.
|
|
1991
|
4 |
3 |
p. 307-308
2 p.
|
article
|
| 191 |
Prefrontal sulcal prominence is inversely related to treatment response to clozapine in schizophrenia
|
Friedman, L.
|
|
1991
|
4 |
3 |
p. 317-
1 p.
|
article
|
| 192 |
Prenatal maldevelopment of the palm/thumb in schizophrenia: A monozygotic twins study
|
Bracha, H.S.
|
|
1991
|
4 |
3 |
p. 274-
1 p.
|
article
|
| 193 |
Prevalence and risk factors of involuntary movement disorders in a neuroleptic treated population: A comparison between schizophrenic spectrum and non-schizophrenic spectrum patients
|
Smeraldi, E.
|
|
1991
|
4 |
3 |
p. 367-368
2 p.
|
article
|
| 194 |
Prolactin bioassay in schizophrenic patients on neuroleptic medication
|
Warner, M.D.
|
|
1991
|
4 |
3 |
p. 295-296
2 p.
|
article
|
| 195 |
Psychoactive substance abuse assesment in schizophrenics
|
Dixon, L.B.
|
|
1991
|
4 |
3 |
p. 382-
1 p.
|
article
|
| 196 |
Pursuit eye movement dysfunction in schizophrenia: Characteristics of oculomotor disturbance and diagnostic specificity
|
Sweeney, J.A.
|
|
1991
|
4 |
3 |
p. 339-
1 p.
|
article
|
| 197 |
Qualitative and quantitative assessment of pre-alpha-cell clusters in the entorhinal cortex of schizophrenics. A neurodevelopmental model of schizophrenia?
|
Falkai, P.
|
|
1991
|
4 |
3 |
p. 357-358
2 p.
|
article
|
| 198 |
Quantification of relative haloperidol occupancy and effects in vivo with a simple dual detector probe
|
Jeffries, K.J.
|
|
1991
|
4 |
3 |
p. 405-406
2 p.
|
article
|
| 199 |
Quantitative assessment of negative symptoms in chronic schizophrenic patients: Severity, response to treatment, and relationship to positive symptoms
|
Boronow, J.J.
|
|
1991
|
4 |
3 |
p. 249-250
2 p.
|
article
|
| 200 |
Quantitative evaluation of astrocyte densities in schizophrenia
|
Falkai, P.
|
|
1991
|
4 |
3 |
p. 358-
1 p.
|
article
|
| 201 |
Quantitative features of eye movement dysfunctions in schizophrenics
|
Levy, D.L.
|
|
1991
|
4 |
3 |
p. 334-335
2 p.
|
article
|
| 202 |
Reduced cerebral glucose utilization in GABAergic nigral efferent target regions in intranigral isoniazid-induced vacuous chewing movements
|
Bachus, S.E.
|
|
1991
|
4 |
3 |
p. 341-
1 p.
|
article
|
| 203 |
Reduced cerebral volume and increased third ventricular volume in schizophrenic patients: A quantitative magnetic resonance imaging study
|
Schwarzkopf, S.B.
|
|
1991
|
4 |
3 |
p. 412-
1 p.
|
article
|
| 204 |
Regional brain glucose metabolism in neuroleptic naive first episode and chronic schizophrenic patients and normal controls at rest and after dopamine agonist and antagonist drugs
|
Cleghorn, J.M.
|
|
1991
|
4 |
3 |
p. 401-402
2 p.
|
article
|
| 205 |
Regional glucose metabolism assessed by PET as a tool for studying clinical response to typical & atypical neuroleptics
|
Potkin, S.G.
|
|
1991
|
4 |
3 |
p. 410-411
2 p.
|
article
|
| 206 |
Registered PET-MRI comparative study of normal volunteers performing a tone discrimination task: the impact of performance error on cortical surface metabolic activity patterns
|
Holcomb, H.H.
|
|
1991
|
4 |
3 |
p. 404-405
2 p.
|
article
|
| 207 |
Reliability and validity of a depression scale for schizophrenics
|
Addington, D.
|
|
1991
|
4 |
3 |
p. 247-
1 p.
|
article
|
| 208 |
Remoxipride therapy in poorly responsive schizophrenics
|
Conley, R.
|
|
1991
|
4 |
3 |
p. 316-
1 p.
|
article
|
| 209 |
Risperidone in the treatment of acute exacerbation of chronic schizophrenia
|
Borison, R.L.
|
|
1991
|
4 |
3 |
p. 314-315
2 p.
|
article
|
| 210 |
Sample bias in neurobiological studies of neuroleptic-naive psychotic subjects
|
Keks, N.A.
|
|
1991
|
4 |
3 |
p. 260-261
2 p.
|
article
|
| 211 |
S(+)-aporphines as potential limbic-selective antipsychotic agents
|
Baldessarini, R.J.
|
|
1991
|
4 |
3 |
p. 312-
1 p.
|
article
|
| 212 |
Schizophrenia and epilepsy: clinical and pathological studies
|
Stevens, J.R.
|
|
1991
|
4 |
3 |
p. 373-374
2 p.
|
article
|
| 213 |
Schizophrenia and schizophreniform disorder: Is there a critical difference?
|
Nuechterlein, K.H.
|
|
1991
|
4 |
3 |
p. 265-266
2 p.
|
article
|
| 214 |
Schizophrenia and social judgement: Why do schizophrenics get it wrong?
|
Cramer, P.
|
|
1991
|
4 |
3 |
p. 301-302
2 p.
|
article
|
| 215 |
Schizophrenia neuroanatomy and theory falsification
|
Carpenter Jr., W.T.
|
|
1991
|
4 |
3 |
p. 251-
1 p.
|
article
|
| 216 |
Schizotypal symptoms and information processing deficits in families of schizophrenic patients
|
Steinhauer, S.R.
|
|
1991
|
4 |
3 |
p. 393-
1 p.
|
article
|
| 217 |
Second messenger imbalance hypothesis of schizophrenia
|
Kaiya, H.
|
|
1991
|
4 |
3 |
p. 348-
1 p.
|
article
|
| 218 |
Segregation analysis of schizophrenia in nine multigenerational pedigrees
|
Plaetke, R.
|
|
1991
|
4 |
3 |
p. 283-
1 p.
|
article
|
| 219 |
Sensory gating deficits in neonatally dopamine depleted animals: Evidence for involvement of mesolimbic dopamine supersensitivity
|
Schwarzkopf, S.B.
|
|
1991
|
4 |
3 |
p. 392-393
2 p.
|
article
|
| 220 |
Serotonin binding sites and metabolites in the brain of schizophrenic suicide victims
|
Conley, R.
|
|
1991
|
4 |
3 |
p. 376-377
2 p.
|
article
|
| 221 |
Serotonin receptor sensitivity in schizophrenia
|
Kahn, R.S.
|
|
1991
|
4 |
3 |
p. 347-348
2 p.
|
article
|
| 222 |
Serotonin-2 receptors in the platelets of schizophrenic patients
|
Pandey, G.N.
|
|
1991
|
4 |
3 |
p. 354-
1 p.
|
article
|
| 223 |
Serum cholinesterase and REM latency in schizophrenia
|
Keshavan, M.
|
|
1991
|
4 |
3 |
p. 334-
1 p.
|
article
|
| 224 |
Should poor premorbid functioning be part of the negative syndrome?
|
Foerster, A.
|
|
1991
|
4 |
3 |
p. 256-257
2 p.
|
article
|
| 225 |
Sleep encephalographic studies in schizophrenic patients: Comparison of neuroleptic-naive and previously-medicated patients with healthy controls
|
Taylor, S.F.
|
|
1991
|
4 |
3 |
p. 339-340
2 p.
|
article
|
| 226 |
Smoking and tardive dyskinesia
|
Cohen, S.
|
|
1991
|
4 |
3 |
p. 361-362
2 p.
|
article
|
| 227 |
Smooth pursuit eye movements in schizophrenia spectrum disorders: Familial vs episodic
|
Thaker, G.
|
|
1991
|
4 |
3 |
p. 268-269
2 p.
|
article
|
| 228 |
Social interaction and schizophrenia: Problem, theory, and research
|
Flack Jr., W.F.
|
|
1991
|
4 |
3 |
p. 303-
1 p.
|
article
|
| 229 |
Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit
|
Deakin, J.F.W.
|
|
1991
|
4 |
3 |
p. 357-
1 p.
|
article
|
| 230 |
Spectral EEG abnormalities following photic driving in schizophrenic patients
|
Jin, Y.
|
|
1991
|
4 |
3 |
p. 333-
1 p.
|
article
|
| 231 |
Spin-spin relaxation time (T2) in schizophrenia
|
Pandurangi, A.
|
|
1991
|
4 |
3 |
p. 408-409
2 p.
|
article
|
| 232 |
Striatal-thalamic disorder of cerebral metabolism in never-medicated schizophrenics
|
Buchsbaum, M.S.
|
|
1991
|
4 |
3 |
p. 401-
1 p.
|
article
|
| 233 |
Structural brain imaging in partial trisomy chromosome 5 with schizophrenia
|
Honer, W.G.
|
|
1991
|
4 |
3 |
p. 278-
1 p.
|
article
|
| 234 |
Studies in skin fibroblasts from chronic schizophrenic patients
|
Mahadik, S.P.
|
|
1991
|
4 |
3 |
p. 372-373
2 p.
|
article
|
| 235 |
Suicide as a risk factor for tardive dyskinesia
|
Sandyk, R.
|
|
1991
|
4 |
3 |
p. 366-
1 p.
|
article
|
| 236 |
Suicide behavior in patients with schizophrenia
|
Asnis, G.M.
|
|
1991
|
4 |
3 |
p. 375-
1 p.
|
article
|
| 237 |
Suicide in schizophrenia: What do we know? where do we go?
|
Wagman, A.M.I.
|
|
1991
|
4 |
3 |
p. 378-379
2 p.
|
article
|
| 238 |
Suicide in young adults with schizophrenic disorders: A prospective study
|
Cohen, L.J.
|
|
1991
|
4 |
3 |
p. 375-376
2 p.
|
article
|
| 239 |
Tardive dyskinesia in the mentally retarded: Prevalence, risk factor and topographic comparison with a schizophrenic population
|
Cohen, S.
|
|
1991
|
4 |
3 |
p. 362-
1 p.
|
article
|
| 240 |
Temporal lobe asymmetries as a clue to the aetiology of schizophrenia
|
Crow, T.J.
|
|
1991
|
4 |
3 |
p. 402-
1 p.
|
article
|
| 241 |
Ten years of studies on P50 sensory gating: A review and considerations for future studies
|
Adler, L.E.
|
|
1991
|
4 |
3 |
p. 329-
1 p.
|
article
|
| 242 |
Testing systems for assessment of negative symptoms in schizophrenia
|
Fenton, W.S.
|
|
1991
|
4 |
3 |
p. 256-
1 p.
|
article
|
| 243 |
The ability of schizophrenics to perceive and cope with negative affect
|
Bellack, A.S.
|
|
1991
|
4 |
3 |
p. 299-300
2 p.
|
article
|
| 244 |
The atypical neuroleptic, remoxipride, and prolactin response in the treatment of acute schizophrenia
|
Awad, A.G.
|
|
1991
|
4 |
3 |
p. 311-
1 p.
|
article
|
| 245 |
The CBF and CMRO2 drug-naive and drug-treated schizophrenia, and presenile dementia: A study using PET
|
Takahashi, H.
|
|
1991
|
4 |
3 |
p. 414-
1 p.
|
article
|
| 246 |
The clinical significance of medial temporal lobe hypoplasia in schizophrenia
|
Nasrallah, H.A.
|
|
1991
|
4 |
3 |
p. 407-
1 p.
|
article
|
| 247 |
The clinical significance of neurophysiological deficits in schizophrenic patients
|
Braff, D.L.
|
|
1991
|
4 |
3 |
p. 331-
1 p.
|
article
|
| 248 |
The 1962 Copenhagen high-risk study: 29 years after
|
Mednick, S.A.
|
|
1991
|
4 |
3 |
p. 281-
1 p.
|
article
|
| 249 |
The correlation of the seasonality of schizophrenic births and stillbirths over a fifty-two year time period
|
Torrey, E.F.
|
|
1991
|
4 |
3 |
p. 269-
1 p.
|
article
|
| 250 |
The cortical regulation of dopamine system responsivity: A hypothesis regarding its role in the etiology of schizophrenia
|
Grace, A.A.
|
|
1991
|
4 |
3 |
p. 345-
1 p.
|
article
|
| 251 |
The deficit syndrome: functional and structural characteristics
|
Buchanan, R.W.
|
|
1991
|
4 |
3 |
p. 400-401
2 p.
|
article
|
| 252 |
The effect of a hospital treatment model on the aftercare compliance rates of a SPMI patient group
|
Sullivan, T.B.
|
|
1991
|
4 |
3 |
p. 308-
1 p.
|
article
|
| 253 |
The effect of early neuroleptic intervention on the course of schizophrenia
|
Wyatt, R.J.
|
|
1991
|
4 |
3 |
p. 297-
1 p.
|
article
|
| 254 |
The effect of ritanserin on slow wave sleep deficits in schizophrenia
|
Benson, K.L.
|
|
1991
|
4 |
3 |
p. 330-
1 p.
|
article
|
| 255 |
The effects of clozapine on dopamine, 5-HT, and glutamate release in the rat medial prefrontal cortex
|
Pehek, E.A.
|
|
1991
|
4 |
3 |
p. 323-324
2 p.
|
article
|
| 256 |
The impact of neuroleptic medications on the incidence of tardive dyskinesia in an outpatient population
|
Glazer, W.M.
|
|
1991
|
4 |
3 |
p. 363-364
2 p.
|
article
|
| 257 |
The influence of cigarette smoking on haloperidol dosing requirements
|
Perry, P.J.
|
|
1991
|
4 |
3 |
p. 292-
1 p.
|
article
|
| 258 |
The Maine-Vermont longitudinal project: The world's only replication study over three decades
|
Harding, C.M.
|
|
1991
|
4 |
3 |
p. 259-
1 p.
|
article
|
| 259 |
The measurement of unawareness of illness in schizophrenia
|
Amador, X.F.
|
|
1991
|
4 |
3 |
p. 248-
1 p.
|
article
|
| 260 |
The neurodevelopmental and adult schizophrenias: Kraepelin lost and Kraepelin found
|
Murray, R.M.
|
|
1991
|
4 |
3 |
p. 282-283
2 p.
|
article
|
| 261 |
The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial
|
Awad, A.G.
|
|
1991
|
4 |
3 |
p. 311-312
2 p.
|
article
|
| 262 |
The New York high-risk project: Comorbidity of axis I disorders in subjects at high risk for schizophrenia or major affective disorders and in low-risk subjects
|
Erlenmeyer-Kimling, L.
|
|
1991
|
4 |
3 |
p. 276-
1 p.
|
article
|
| 263 |
The New York high-risk project: History of study, overview of marker findings to date and prevalence of axis I high and low risk subjects
|
Cornblatt, B.
|
|
1991
|
4 |
3 |
p. 275-
1 p.
|
article
|
| 264 |
The pervasiveness of cognitive and behavioral treatment interventions in the schizophrenic's rehabilitation
|
Brenner, H.D.
|
|
1991
|
4 |
3 |
p. 301-
1 p.
|
article
|
| 265 |
The pharmacological profile of U-86170F, a dopamine autoreceptor agonist
|
Lahti, R.A.
|
|
1991
|
4 |
3 |
p. 320-
1 p.
|
article
|
| 266 |
The predictive utility of schizophrenic symptoms in patients with a recent episode of mania
|
Miklowitz, D.J.
|
|
1991
|
4 |
3 |
p. 264-
1 p.
|
article
|
| 267 |
The Queensland follow-up study. Schizo-affective psychosis: Phenomenology and outcome
|
Varghese, F.T.
|
|
1991
|
4 |
3 |
p. 270-
1 p.
|
article
|
| 268 |
The scope of the schizophrenic spectrum: results of a family study
|
Maier, W.
|
|
1991
|
4 |
3 |
p. 263-
1 p.
|
article
|
| 269 |
The search for novel antipsychotics: Agents with a targeted activity in particular brain regions such as hippocampus—the example of savoxepine
|
Bischoff, S.
|
|
1991
|
4 |
3 |
p. 313-314
2 p.
|
article
|
| 270 |
The subjective experience of negative symptoms and body image disturbance in schizophrenia
|
Cutbush, J.
|
|
1991
|
4 |
3 |
p. 253-254
2 p.
|
article
|
| 271 |
The validity of wisconsin card sorting test factors as measures of dorsolateral prefrontal cortical function in schizophrenia and alcoholism
|
Sullivan, E.V.
|
|
1991
|
4 |
3 |
p. 394-395
2 p.
|
article
|
| 272 |
Thought disorder in the siblings of schizophrenic patients
|
Hall, J.K.
|
|
1991
|
4 |
3 |
p. 277-278
2 p.
|
article
|
| 273 |
Time course of psychopathologic and dyskinetic motor changes after blind neuroleptic withdrawal
|
Dixon, L.
|
|
1991
|
4 |
3 |
p. 288-
1 p.
|
article
|
| 274 |
Towards DSM-IV schizophrenia: The application of three proposed schemata to prospectively collected data
|
Copolov, D.L.
|
|
1991
|
4 |
3 |
p. 252-253
2 p.
|
article
|
| 275 |
To what degree do negative symptoms and social adaptation influence motivation towards regular participation in group therapy by schizophrenic outpatients?
|
Schmitz-Niehues, B.
|
|
1991
|
4 |
3 |
p. 308-
1 p.
|
article
|
| 276 |
Treatment of borderline personality disorder with serotonin 1a agonist and psychotherapy
|
Wolf, M.
|
|
1991
|
4 |
3 |
p. 328-
1 p.
|
article
|
| 277 |
Two nonhuman primate social colony models for screening novel antipsychotic candidates
|
Schlemmer Jr., R.F.
|
|
1991
|
4 |
3 |
p. 325-326
2 p.
|
article
|
| 278 |
Use of a sigma receptor ligand, BMY 14802, for the treatment of schizophrenia
|
Gewirtz, G.R.
|
|
1991
|
4 |
3 |
p. 317-318
2 p.
|
article
|
| 279 |
Using quantitative trait data to discriminate among genetic models of schizophrenia
|
Moldin, S.O.
|
|
1991
|
4 |
3 |
p. 281-
1 p.
|
article
|
| 280 |
Validity of the deficit syndrome
|
Carpenter Jr., .T.
|
|
1991
|
4 |
3 |
p. 251-252
2 p.
|
article
|
| 281 |
Vocal acoustic correlates of flat affect: Contrast with other negative signs and depression
|
Alpert, M.
|
|
1991
|
4 |
3 |
p. 247-248
2 p.
|
article
|
| 282 |
Volumetric measurements of cerebral gray and white matter and cerebrospinal fluid space (CSF) in chronic schizophrenic patients and controls
|
Woods, B.T.
|
|
1991
|
4 |
3 |
p. 414-
1 p.
|
article
|
| 283 |
Weight gain in clozapine treated schizophrenics
|
Lamberti, J.S.
|
|
1991
|
4 |
3 |
p. 320-321
2 p.
|
article
|
| 284 |
Why isn't schizophrenia disappearing in Nottingham?
|
Harrison, G.
|
|
1991
|
4 |
3 |
p. 259-
1 p.
|
article
|
| 285 |
2-year-outcome of intermittent vs. maintenance neuroleptic treatment in schizophrenia
|
Gaebel, W.
|
|
1991
|
4 |
3 |
p. 288-289
2 p.
|
article
|
Journal description